Concepedia

Kinga Winiarczyk

KW

Statistics

Publications

6

Citations

213

H-Index

6

Active since

2012

Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology(Current)

Medical University of Lublin

Poznan University of Medical Sciences

Postgraduate School of Molecular Medicine

Instytut Medycyny Wsi im. Witolda Chodźki

Kinga Winiarczyk is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in non-coding rna, immunology, and prognostic biomarkers.

ORCID

Top concepts

Publications per year

2012–2017

6

Publications

6

Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers

Tomasz Powrózek, Paweł Krawczyk, Dariusz M. Kowalski et al. · Translational research · 2015 · 67 citations

, , +8

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations

Paweł Krawczyk, Dariusz M. Kowalski, Rodryg Ramlau et al. · Oncology Letters · 2017 · 64 citations · Full text

Application of plasma circulating microRNA-448, 506, 4316, and 4478 analysis for non-invasive diagnosis of lung cancer

Tomasz Powrózek, Paweł Krawczyk, Dariusz M. Kowalski et al. · Tumor Biology · 2015 · 30 citations

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients

Paweł Krawczyk, Tomasz Kucharczyk, Dariusz M. Kowalski et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 27 citations · Full text

The Qualification of Docetaxel or Erlotinib for Second-Line Therapy Should Be Based on Clinical and Molecular Predictive Factors

Paweł Krawczyk, Dariusz M. Kowalski, Kamila Wojas‐Krawczyk et al. · Chemotherapy · 2012 · 15 citations

1–5 of 6